Agenda

Psychopharmacology is more than medication. It’s the chemistry of change, the art of symptom relief, and the daily challenge of treating real people with complex, evolving stories.


NEI’s agenda is designed to give clinicians real-world tools to manage complex psychiatric care. From first-line decisions to treatment-resistant cases, every session is grounded in the realities of clinical work.

Register Now

The full 2026 scientific agenda* will be announced soon.

Wednesday, November 4

Child & Adolescent Psychiatry Academy

9:00 am – 6:15 pm

Academy Check–In & Help Desk Open

1:00 pm – 6:00 pm

Child & Adolescent Psychiatry Academy Sessions

Separate registration required

  • You Need To Calm Down: Addressing Irritability and Emotional Dysregulation in Youth with Autism Spectrum Disorder
  • Should I Stay or Should I Go? Using Dopamine Receptor Blocking Agents in Pediatrics
  • Under Pressure: Addressing Picky, Restricted, or Disordered Eating in Children and Adolescents
  • Don’t You Worry Child: Practical and Evidence-Based Care of Pediatric Anxiety
  • I Still Haven’t Found What I’m Looking For: Pediatric ADHD in the Real World, Strategic Treatment Planning for Complex Cases

Thursday, November 5

Pre-Conference Workshop: Sleep

8:10 am – 11:50 am

Pre–Conference Seminar Sessions

Separate registration required

  • Rolling in the Deep of Sleep: Neurotransmitters, Architecture, and Practical Diagnosis
  • The Fate of Orexins: Their Expanding Role in Insomnia, Hypersomnia, and Depression
  • How It’s Done: Practical Case-Based Strategies for Sleep Disorders

12:00 pm – 1:00 pm

Lunch Industry Session†

NEI Fall Congress

1:00 pm – 6:00 pm

NEI Fall Congress General Sessions

  • Switching Gears in MDD: When, Why, and How to Use Glutamatergic Therapies to Optimize Functional Outcomes
  • Challenge Accepted: Strategies to Overcome Difficult-to-Treat Depression
  • More Than Meets the Eye: Transforming Care for Depression Across Bipolar Spectrum Disorders
  • Gaining Insight Into Anosognosia as a Barrier to Treatment of Schizophrenia Spectrum Disorders
  • Time Is Brain: Early Adoption of Long-Acting Injectables To Improve Functional Outcomes in Serious Mental Illness
  • Abandonment Dressed As Autonomy: Policy as a Barrier to Evidence-based Treatment of Schizophrenia Spectrum Disorders

Friday, November 6

8:10 am – 6:30 pm

NEI Fall Congress General Sessions

  • Reframing Schizophrenia Treatment: The Why, When, and How of Muscarinic Agonists
  • From “Anxious” to Accurate: Neurobiology, Diagnostic Clarity, and Emerging Directions in Generalized Anxiety Disorder
  • From Residual to Recovery: Shared Decision Making in MDD to Reduce Residual Symptoms, Prevent Recurrence, and Lower Suicide Risk
  • Seen and Unseen: The Hidden Toll of Tardive Dyskinesia
  • AIMS Demonstration
  • Steady Hands, Steady Minds: From Evidence to Empowerment in TD Treatment
  • Missed, Delayed, Untreated: Fixing the AUD Care Cascade From Identification to Long-Term Recovery

Breakfast† and Lunch† Provided

Saturday, November 7

8:10 am – 6:30 pm

NEI Fall Congress General Sessions

  • Residual Symptoms in ADHD: From Circuitry to Clinical Strategy
  • Before Memory Fails: Identifying Alzheimer’s Disease Early to Enable Timely Intervention
  • There’s No Place Like Home: Practical Strategies to Manage Agitation in Alzheimer’s Disease and Support Caregivers
  • From Stigma to Superpower: Reframing Mental Health Disorders through Creativity and Contribution
  • Telehealth on Trial: Lessons From the Done.com Case for Safe and Ethical Prescribing
  • Scientific Poster Reception (CE & Non-CE Posters)

Breakfast† and Lunch† Provided

Sunday, November 8

8:10 am – 12:30 pm

NEI Fall Congress General Sessions

  • Letting Go: The Art and Science of Deprescribing in Psychiatry
  • Old Time Pharmaco: Psychotic Disorders
  • Old Time Pharmaco: Mood Disorders
  • Access Denied? Practical Strategies to Overcome Barriers to Prescribing the Most Appropriate Psychiatric Treatments

Breakfast† Provided


*The agenda is subject to change.

†The content of all industry–sponsored non–CE events (industry session, disease state sessions, and poster sessions) and the views expressed therein are those of the presenting entity and not of NEI. Non–CE events are not part of the accredited program and do not provide CE credit. By attending (or opening) a non–CE event, the attendee opts in to receive follow–up information from the commercial sponsor. Meals for in-person attendees are provided by NEI.



Register Now


Circuits to Symptoms Illustration

Every Symptom Has a Backstory

Understand how neurotransmitters like serotonin, dopamine, and GABA shape behavior, response, and side effects. Through powerful visuals and case-based learning, you’ll see how neurobiology informs everything from diagnosis to medication choice.

Guidelines & Switching Illustration

You’ve Seen the Guidelines & Algorithms. Now Get the Nuance

Dive into the human reality behind every diagnosis with sessions that explore the subtle decisions that come with prescribing in the gray zones: partial responders, overlapping symptoms, and patients who defy categories. You’ll gain clear strategies for titration, augmentation, and medication sequencing.

Struggling Patient Illustration

Patients Show Up Mid-Crisis, Mid-Taper, Mid-Doubt

Sessions made for the real-world and nonlinear side of psychopharmacology, including side effect management, pharmacokinetics, adherence struggles, drug interactions, and when psychopharmacology becomes psychotherapy by proxy.